SCHEMBL2462973

SCHEMBL2462973

O=c1c(CCc2cccc(Cl)c2)c(C2CCC2)[nH]c2ncnn12

nearest known ligand 0.39

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 4/20 0.39
CCR5 P51681 2/20 0.39
PDE2A O00408 3/20 0.38
DAO P14920 3/20 0.37
PDE1B Q01064 4/20 0.37
PLAT P00750 2/20 0.36
ADORA1 P30542 1/20 0.35
PDE9A O76083 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2460219 0.91 CCR2 (0.46) CCR2CCR5PDE2APDE1BPLAT
SCHEMBL2456663 0.89 CCR2 (0.48) CCR2CCR5PDE2APDE1BPLAT
SCHEMBL2456565 0.87 CCR2 (0.50) CCR2CCR5PDE1BPLAT
SCHEMBL2457070 0.82 CCR2 (0.44) CCR2CCR5PDE1BPLAT
SCHEMBL2457418 0.80 CCR2 (0.42) CCR2CCR5PDE2APDE1BPLAT
SCHEMBL2454681 0.79 PDE2A (0.44) CCR2CCR5PDE2ADAOPDE1B
SCHEMBL2460011 0.79 CCR2 (0.43) CCR2CCR5PDE2A
SCHEMBL2464957 0.79 NR3C1 (0.33) CCR2CCR5PDE2AADORA1
SCHEMBL2455160 0.79 CCR2 (0.43) CCR2PDE2ADAOPDE1B
SCHEMBL2456672 0.78 CCR2 (0.41) CCR2CCR5PDE1BPLAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO claimed
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO disclosed
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO disclosed